Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2015 Oct 14

PMID 26459897

Citations 24

Authors

Ji-Young Lee

Myung-Jin Choi

Hyeon Jin Choi

Kwan Soo Ko

Affiliations

Soon will be listed here.

Abstract

Colistin-resistant mutants were obtained from 17 colistin-susceptible strains of Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli. The stability of colistin resistance in these mutants was investigated. Three of four colistin-resistant P. aeruginosa mutants recovered colistin susceptibility in colistin-free medium; however, colistin-susceptible revertants were obtained from only one strain each of A. baumannii and E. coli. No susceptible revertants were obtained from K. pneumoniae mutants.

Citing Articles

Impact of porin deficiency on the synergistic potential of colistin in combination with β-lactam/β-lactamase inhibitors against ESBL- and carbapenemase-producing .

Allander L, Vickberg K, Fermer E, Soderhall T, Sandegren L, Lagerback P Antimicrob Agents Chemother. 2024; 68(11):e0076224.

PMID: 39365067 PMC: 11539213. DOI: 10.1128/aac.00762-24.

Resensitization to colistin results in rapid and stable recovery of adherence, serum resistance and ompW in Acinetobacter baumannii.

Boral J, Vatansever C, Ozcan G, Keske S, Menekse S, Gonen M PLoS One. 2024; 19(8):e0309307.

PMID: 39196973 PMC: 11356438. DOI: 10.1371/journal.pone.0309307.

IS-mediated chromosomal amplification of the operon leads to polymyxin B resistance in B strains.

Maybin M, Ranade A, Schombel U, Gisch N, Mamat U, Meredith T mBio. 2024; 15(7):e0063424.

PMID: 38904391 PMC: 11253626. DOI: 10.1128/mbio.00634-24.

Quantifying combined effects of colistin and ciprofloxacin against Escherichia coli in an in silico pharmacokinetic-pharmacodynamic model.

Zhao C, Kristoffersson A, Khan D, Lagerback P, Lustig U, Cao S Sci Rep. 2024; 14(1):11706.

PMID: 38778123 PMC: 11111785. DOI: 10.1038/s41598-024-61518-0.

Influence of PhoPQ and PmrAB two component system alternations on colistin resistance from non-mcr colistin resistant clinical E. Coli strains.

Wang C, Siu L, Chang F, Tsai Y, Huang L, Lin J BMC Microbiol. 2024; 24(1):109.

PMID: 38565985 PMC: 10986093. DOI: 10.1186/s12866-024-03259-8.

References

Lau S, Reddy S, Cheesbrough J, Bolton F, Willshaw G, Cheasty T . Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J Clin Microbiol. 2008; 46(3):1076-80. PMC: 2268376. DOI: 10.1128/JCM.02065-07. View

Lopez-Rojas R, Jimenez-Mejias M, Lepe J, Pachon J . Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain. J Infect Dis. 2011; 204(7):1147-8. DOI: 10.1093/infdis/jir476. View

Choi M, Ko K . Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains. Antimicrob Agents Chemother. 2015; 59(11):6763-73. PMC: 4604379. DOI: 10.1128/AAC.00952-15. View

Pournaras S, Poulou A, Dafopoulou K, Nait Chabane Y, Kristo I, Makris D . Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii. Antimicrob Agents Chemother. 2013; 58(2):828-32. PMC: 3910856. DOI: 10.1128/AAC.01439-13. View

Lee J, Lim M, Heo S, Ko K . Repeated isolation of Pseudomonas aeruginosa isolates resistant to both polymyxins and carbapenems from 1 patient. Diagn Microbiol Infect Dis. 2012; 72(3):267-71. DOI: 10.1016/j.diagmicrobio.2011.11.014. View

Lee J, Song J, Ko K . Identification of nonclonal Pseudomonas aeruginosa isolates with reduced colistin susceptibility in Korea. Microb Drug Resist. 2011; 17(2):299-304. DOI: 10.1089/mdr.2010.0145. View

Yau W, Owen R, Poudyal A, Bell J, Turnidge J, Yu H . Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme. J Infect. 2008; 58(2):138-44. DOI: 10.1016/j.jinf.2008.11.002. View

Curran B, Jonas D, Grundmann H, Pitt T, Dowson C . Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol. 2004; 42(12):5644-9. PMC: 535286. DOI: 10.1128/JCM.42.12.5644-5649.2004. View

Wright M, Suzuki Y, Jones M, Marshall S, Rudin S, van Duin D . Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance. Antimicrob Agents Chemother. 2014; 59(1):536-43. PMC: 4291396. DOI: 10.1128/AAC.04037-14. View

10.

Suh J, Son J, Chung D, Peck K, Ko K, Song J . Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea. Antimicrob Agents Chemother. 2009; 54(1):560-2. PMC: 2798536. DOI: 10.1128/AAC.00762-09. View

11.

Bartual S, Seifert H, Hippler C, Dominguez Luzon M, Wisplinghoff H, Rodriguez-Valera F . Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005; 43(9):4382-90. PMC: 1234098. DOI: 10.1128/JCM.43.9.4382-4390.2005. View

12.

Lee J, Ko K . Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates. Diagn Microbiol Infect Dis. 2014; 78(3):271-6. DOI: 10.1016/j.diagmicrobio.2013.11.027. View

13.

Choi M, Ko K . Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates. J Antimicrob Chemother. 2013; 69(1):275-7. DOI: 10.1093/jac/dkt315. View

14.

Olaitan A, Diene S, Kempf M, Berrazeg M, Bakour S, Gupta S . Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents. 2014; 44(6):500-7. DOI: 10.1016/j.ijantimicag.2014.07.020. View

15.

El-Halfawy O, Valvano M . Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev. 2015; 28(1):191-207. PMC: 4284305. DOI: 10.1128/CMR.00058-14. View

16.

Park Y, Choi J, Shin D, Ko K . Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii. Int J Antimicrob Agents. 2011; 37(6):525-30. DOI: 10.1016/j.ijantimicag.2011.02.008. View

17.

Snitkin E, Zelazny A, Gupta J, Palmore T, Murray P, Segre J . Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment. Genome Res. 2013; 23(7):1155-62. PMC: 3698508. DOI: 10.1101/gr.154328.112. View

18.

Olaitan A, Morand S, Rolain J . Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014; 5:643. PMC: 4244539. DOI: 10.3389/fmicb.2014.00643. View

19.

Skiada A, Markogiannakis A, Plachouras D, Daikos G . Adaptive resistance to cationic compounds in Pseudomonas aeruginosa. Int J Antimicrob Agents. 2011; 37(3):187-93. DOI: 10.1016/j.ijantimicag.2010.11.019. View

20.

Diancourt L, Passet V, Verhoef J, Grimont P, Brisse S . Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005; 43(8):4178-82. PMC: 1233940. DOI: 10.1128/JCM.43.8.4178-4182.2005. View